中国给水排水
中國給水排水
중국급수배수
CHINA WATER & WASTEWATER
2010年
8期
41-44,49
,共5页
合成制药废水%水解酸化%NH_3-N
閤成製藥廢水%水解痠化%NH_3-N
합성제약폐수%수해산화%NH_3-N
synthetic pharmaceutical wastewater%hydrolysis acidification%NH_3-N
采用预处理/水解酸化/A-O/NSBR/混凝沉淀工艺处理高浓度合成制药废水,在进水COD≤5 000 mg/L、NH_3-N≤100 mg/L、有机氮≤150 mg/L的情况下,生化处理出水COD<300mg/L、NH_3-N≤50 mg/L,达到了预期效果.
採用預處理/水解痠化/A-O/NSBR/混凝沉澱工藝處理高濃度閤成製藥廢水,在進水COD≤5 000 mg/L、NH_3-N≤100 mg/L、有機氮≤150 mg/L的情況下,生化處理齣水COD<300mg/L、NH_3-N≤50 mg/L,達到瞭預期效果.
채용예처리/수해산화/A-O/NSBR/혼응침정공예처리고농도합성제약폐수,재진수COD≤5 000 mg/L、NH_3-N≤100 mg/L、유궤담≤150 mg/L적정황하,생화처리출수COD<300mg/L、NH_3-N≤50 mg/L,체도료예기효과.
Pretreatment-hydrolysis acidification - A/O - NSBR - coagulation and sedimentation process was used to treat high-concentration organic synthetic pharmaceutical wastewater. When the influ-ent COD, NH_3-N and organic nitrogen are equal to or less than 5 000 mg/L, 100 mg/L and 150 mg/L respectively, the effluent COD and NH_3-N are less than 300 mg/L and 50 mg/L respectively. The ex-pected result is reached.
